Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma.

Takata A, Takiguchi S, Okada K, Takahashi T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Mori M, Doki Y.

Anticancer Res. 2014 May;34(5):2427-32.

PMID:
24778055
2.

Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.

Hui MK, Chan KW, Luk JM, Lee NP, Chung Y, Cheung LC, Srivastava G, Tsao SW, Tang JC, Law S.

World J Surg. 2012 Jan;36(1):90-7. doi: 10.1007/s00268-011-1302-5.

3.

Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.

Yang DK, Son CH, Lee SK, Choi PJ, Lee KE, Roh MS.

Hum Pathol. 2009 Apr;40(4):464-70. doi: 10.1016/j.humpath.2008.10.001. Epub 2009 Jan 3.

PMID:
19121844
4.

[Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].

Gai L, Mao GX, Liu J, Huang H, Wang X, Yao NH.

Zhonghua Zhong Liu Za Zhi. 2016 Mar 23;38(3):179-84. doi: 10.3760/cma.j.issn.0253-3766.2016.03.004. Chinese.

PMID:
26988822
5.

Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Li LY, Li EM, Wu ZY, Cao HH, Shen JH, Xu XE, Chen B, Wu JY, Xu LY.

Int J Clin Exp Pathol. 2014 May 15;7(6):3132-40. eCollection 2014.

6.

Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.

Zhang J, Yang Y, Chen L, Zheng D, Ma J.

Acta Histochem. 2014 Apr;116(3):435-9. doi: 10.1016/j.acthis.2013.09.011. Epub 2013 Oct 28.

PMID:
24176776
7.

Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.

Makino T, Yamasaki M, Takemasa I, Takeno A, Nakamura Y, Miyata H, Takiguchi S, Fujiwara Y, Matsuura N, Mori M, Doki Y.

Ann Surg Oncol. 2009 Jul;16(7):2058-64. doi: 10.1245/s10434-009-0476-7. Epub 2009 Apr 30.

PMID:
19408050
8.

Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.

Shirakawa M, Fujiwara Y, Sugita Y, Moon JH, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Mori M, Doki Y.

Oncol Rep. 2012 Apr;27(4):940-6. doi: 10.3892/or.2011.1607. Epub 2011 Dec 22.

9.

Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.

Wei R, Shang Z, Leng J, Cui L.

J Cancer Res Ther. 2016 Oct-Dec;12(4):1291-1297. doi: 10.4103/0973-1482.180616.

10.

High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.

Hao CL, Li Y, Yang HX, Luo RZ, Zhang Y, Zhang MF, Cheng YF, Wang X.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4213-21. eCollection 2014.

11.

[Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].

Liu HB, Yang QC, Shen Y, Zhu Y, Zhang XJ, Chen H.

Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):361-5. doi: 10.3760/cma.j.issn.0253-3766.2013.05.009. Chinese.

PMID:
24054013
12.

The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

Kim SH, Kim JH, Yu EJ, Lee KW, Park CK.

Histol Histopathol. 2012 Jan;27(1):49-58. doi: 10.14670/HH-27.49.

PMID:
22127596
13.

The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.

Ning ZH, Zhao W, Li XD, Chen LJ, Xu B, Gu WD, Shao YJ, Xu Y, Huang J, Pei HL, Jiang JT.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6881-90. eCollection 2015.

14.

Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma.

Shiozaki A, Nakashima S, Ichikawa D, Fujiwara H, Konishi H, Komatsu S, Kubota T, Okamoto K, Iitaka D, Shimizu H, Nako Y, Takemoto K, Kishimoto M, Otsuji E.

Anticancer Res. 2013 Oct;33(10):4329-35.

PMID:
24123000
15.

Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.

Yang Z, Cui Y, Ni W, Kim S, Xuan Y.

J Cancer Res Clin Oncol. 2017 Feb;143(2):243-254. doi: 10.1007/s00432-016-2273-6. Epub 2016 Sep 28.

PMID:
27680978
16.

Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.

Zhang Y, Zhang YL, Chen HM, Pu HW, Ma WJ, Li XM, Ma H, Chen X.

World J Gastroenterol. 2014 May 14;20(18):5533-9. doi: 10.3748/wjg.v20.i18.5533.

17.

Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.

Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H.

J Surg Oncol. 2005 May 1;90(2):89-94.

PMID:
15844180
18.

Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.

Tang X, Fan Z, Wang Y, Ji G, Wang M, Lin J, Huang S.

Dis Esophagus. 2016 Apr;29(3):207-14. doi: 10.1111/dote.12289. Epub 2014 Oct 6.

PMID:
25287007
19.

Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.

Yang ZT, Yeo SY, Yin YX, Lin ZH, Lee HM, Xuan YH, Cui Y, Kim SH.

PLoS One. 2016 Jan 5;11(1):e0145807. doi: 10.1371/journal.pone.0145807. eCollection 2016.

20.

Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.

Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Sakamoto A, Owaki T, Aikou T.

J Exp Clin Cancer Res. 2009 Dec 21;28:158. doi: 10.1186/1756-9966-28-158.

Supplemental Content

Support Center